Deutsche Bank Resumes Costco Coverage with Bullish Outlook
Deutsche Bank analyst resumes Costco coverage with Buy rating and $1,044 price target, citing defensive strengths despite mixed 2026 retail outlook.
NOTRELOAD AI
ELVN-001 Shows 69% Response Rate in CML Phase 1b Trial Results
Enliven Therapeutics (ELVN) reports encouraging Phase 1b results for ELVN-001, a new treatment for chronic myeloid leukemia, with strong response rates and excellent safety profile.
MoonLake Gets FDA Green Light for HS Treatment Approval Path
MoonLake Immunotherapeutics receives positive FDA feedback, clearing pathway to submit drug application for hidradenitis suppurativa treatment without additional trials needed.
flyExclusive Partners with Starlink for High-Speed In-Flight Wi-Fi
flyExclusive becomes authorized Starlink aviation dealer, bringing super-fast internet to private jets with speeds up to 310 Mbps for seamless streaming and video calls.
FDA Rejects Vanda's Hetlioz for Jet Lag—Shares Drop 12%
Vanda Pharmaceuticals stock falls in premarket trading after FDA denies Hetlioz approval for jet lag disorder, citing clinical trial design concerns despite positive efficacy data.
Morgan Stanley Changes Ratings on RCUS, NRIX, IOBT
Morgan Stanley updates biotech views, downgrading Arcus and IO Biotech while upgrading Nurix on stronger pipeline prospects.